Investor Contact: Carrie Mendivil investors@guardanthealth.com Media Contact: Anna Czene press@guardanthealth.com Courtney Carroll courtney.carroll@uncappedcommunications.com 11/13/2020 Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … ","thumbnailUrl":"https:\/\/www.investors.com\/wp-content\/uploads\/2018\/10\/10-4-640x360.jpg","contentUrl":"https:\/\/content.jwplatform.com\/manifests\/I6vXUhwl.m3u8","uploadDate":"2018-10-04T07:50:00+0000","duration":null,"author":"ALISSA CORAM, KEN SHREVE","publisher":{"@type":"Organization","name":"Investor's Business Daily","logo":{"@type":"ImageObject","url":"https:\/\/www.investors.com\/wp-content\/uploads\/2020\/06\/ibd-logo.png"},"url":"https:\/\/www.investors.com"},"keywords":""}. Deck the halls with bigger profits! Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. Investors. Check out today’s deal before it expires…. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. At the end of the latest market close, Guardant Health Inc. (GH) was valued at $118.66. Jim Crumly … Their latest funding was raised on Aug 6, 2018 from a Venture - Series Unknown round. Which Companies Are Now Outperforming 95% Of All Stocks? Guardant Health has raised a total of $550M in funding over 8 rounds. Guardant Health last raised $360M false. Investors that wish to register for the company’s conference call can do so using this link. Which investors participated in the most funding rounds? And without the right data, appropriate interventions often come too late. Guardant Health Inc is a precision oncology company. It closed up 69.47 percent at $32.20 per share. Guardant Health, Inc. Reconciliation of Net Loss Attributable to Guardant Health, Inc. Common Stockholders (1) to Non-GAAP Adjusted EBITDA (unaudited) (in thousands) Three Months Ended September 30, With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the GH stock to lose ahead of the earnings release. Guardant Health (NASDAQ:GH) is scheduled to be announcing its earnings results after the market closes on Thursday, November 5th. Authors may own the stocks they discuss. {"@context":"https:\/\/schema.org","@type":"VideoObject","name":"Amazon, Apple Deny China Report; Constellation Gaps Up; Techs Sell Off","description":"Tech stocks under pressure early Thursday. Guardant was founded in 2012 in Redwood City, Calif. Subscription includes access to all devices. GUARDANT HEALTH AKTIE und aktueller Aktienkurs. Guardant Health went on the Nasdaq yesterday under the symbol GH. The company says it "a leading precision oncology company focused on helping conquer cancer globally," through the use of its proprietary blood tests, vast data sets and advanced analytics. Get these newsletters delivered to your inbox & more info about our products & services. Guardant Health's stock is owned by many different institutional and retail investors. Soon, it could detect cancer earlier than ever before. Guardant shares closed at 32.20, up 69.5% on the stock market today. Shares climbed almost 70 percent on the first day of trading, selling 12.5 million shares at $19 per share in the initial public offering (IPO). Get market updates, educational videos, webinars, and stock analysis. Media inquiries: press@guardanthealth.com © The Guardant Health IPO priced 12.5 million shares at 19. Ownership data provided by Refinitiv and Estimates data provided by FactSet. How much funding has this organization raised over time? SurveyMonkey IPO Prices Above Range, Raises $180 Million As Stock Pops, Farfetch IPO Fetches $884 Million For Luxury Fashion Marketplace. Amazon, Apple pressured on a China report. Moreover, the addressable markets stated above are only for the US. In that particular session, Stock kicked-off at the price of $119.30 while reaching the peak value of $121.36 and lowest value recorded on the day was $117.00. Investors are urged not to rely on any forward-looking statement in reaching any conclusion or making any investment decision about any securities of Guardant Health… The stock continued to move up. Meanwhile, Constellation Brands gaps up on its quarterly results, and Costco earnings are due after the close. Their stock opened with $19.00 in its Oct 4, 2018 … BREAKING: Stocks Jump At The Close On Stimulus Hopes. Which funding types raised the most money? Cancer is data starved. Illumina, Exact Sciences deals heating... 11/13/2020 Guardant Health (GH) delivered earnings and revenue surprises of -129.41% and 12.18%, respectively, for the quarter ended September 2020. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Shares of Guardant Health (GH) jumped by double-digits Thursday, after raising $238 million in an initial public offering that exceeded expectations. Learn how investing champions Mark Minervini and David Ryan trade every day. The stock current value is $121.12. Which types of acquisition does this organization make most frequently. Guardant has a market cap of $11.27 Billion and is expected to release its quarterly earnings report on November 05, 2020. Data source: investor presentation. (1) Net Loss attributable to Guardant Health, Inc. common stockholders is the most directly comparable GAAP operating financial measure. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. Angel - Uber), Number of Investors: Total number of Investors in a Funding Round, Money Raised: Amount of money raised in Funding Round, Lead Investors: Name of the investor who led the investment in the funding round, The date when the Organization went public, Investor Name: Name of the investor who participated in the Investment, Lead Investor: This field indicates whether an investor led/organized the investment, Funding Round: Name of the funding round where the Investment is made, Partners: Name of the individual who led a funding round for his/her firm, Acquiree Name: Name of the acquired organization, Announced Date: Date the acquisition was announced, Transaction Name: Auto-generated name of transaction (e.g. Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. Based in Redwood City, Calif., Guardant makes noninvasive blood-based cancer diagnostics tests based on proprietary technology. Guardant Health stock is working on a cup base with a 100.10 entry point. Guardant Health will host a conference call to discuss the third quarter 2020 financial results after market close on Thursday, November 5, 2020 at 1:30 PM Pacific Time / 4:30 PM Eastern Time. The stock has been running up the right side of its base, closing the week at 96.14. Guardant Health has a joint venture with Softbank to take its products internationally. Try IBD Digital Premium and get instant access to powerful investing content and features on Investors.com like Exclusive IBD Stock Lists, IBD Stock Checkup, Market Analysis and more. Load up your sleigh and save hundreds on IBD’s Online Courses! The information and content are subject to change without notice. Guardant Health (NASDAQ:GH) last issued its […] The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. The company operates in delivering … Find out why economists and analysts are considering the longer term possibility of a "K" shaped recovery, Stocks Jump At The Close On Stimulus Hopes, Nasdaq Rebounds, Holds Support At 50-Day Line, Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail, Dow Jones Futures: Stock Market Rally Gets A Win, Apple In Buy Zone; Tesla Rival Nikola Sinks On SEC Probe, Intuitive Surgical, Edwards Lifesciences Lead Five Top Stocks To Watch As Coronavirus Cases Fall, Elective Procedures Rise, Guardant Health Coronavirus Test Gets Emergency OK, How Genetic Testing For Cancer Could Create A $51 Billion U.S. Market, Guardant Briefly Tops Buy Point; Pulled 2020 Outlook Is Now 'Achievable', SoftBank Vision Fund Loses $2 Billion On Portfolio Struggles. Register now! Liquid biopsy technology offers promise of the medical Holy Grail,... Get instant access to exclusive stock lists, expert market analysis and powerful tools with 5 weeks of IBD Digital for only $5! The Guardant Health IPO listed on the Nasdaq under the ticker GH. Nachrichten zur Aktie Guardant Health Inc Registered Shs | A2N5RY | GH | US40131M1099 X Guardant Health General Information Description. The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. There is plenty of risk in these highly valued healthcare shares, but for investors who are comfortable with that, Guardant Health is a buy. Guardant Health is registered under the ticker NASDAQ:GH . Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). That was above its estimated range of 15 to 17. "Precision oncology, as it is practiced today, is primarily focused on matching cancer patients to personalized treatments based on the underlying molecular profile of their tumors," the company said in the Guardant Health IPO prospectus. Do the … Shares of Guardant Health jumped by double-digits Thursday, after raising $238 million in an initial public offering that exceeded expectations.. X. Privacy Policy & Terms of Use. Here Are The 6 Stocks That Will Shake Up The Nasdaq. Currently, all revenue is generated from Guardant360 and GuardantOMNI, but that hasn't limited growth. Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. *Real-time prices by Nasdaq Last Sale. Analysts expect the company to announce earnings of ($0.34) per share for the quarter. Telephone: 855.698.8887 Fax: 888.974.4258. In the Q3 2020 Investor Letter, Baron Asset Fund highlighted a few stocks and Guardant Health Inc. (NASDAQ:GH) is one of them.Guardant Health Inc. (NASDAQ:GH) is a … Guardant Health thinks that the market for LUNAR-2 could be more than twice that level -- in the U.S. alone. Realtime quote and/or trade prices are not sourced from all markets. Guardant Health doesn't appear a compelling earnings-beat candidate. The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. Guardant Health is still in its infancy and has a huge runway of growth with an estimated revenue of just US$200 million for 2019. International opportunity. Contact us: clientservices@guardanthealth.com. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Bellwether Bio acquired by Guardant Health, Stock ticker symbol (e.g. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and Liquid biopsy technology offers promise of the medical Holy Grail, early detection of multiple cancers. Shares opened at 27.75 for an initial gain of 46%. Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. © 2000-2020 Investor's Business Daily, Inc. All rights reserved, We’ve got 12 big deals on premium IBD products! Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. AAPL, FB, TWTR), Total amount raised across all funding rounds, Total number of lead investment firms and individual investors, Total number of investment firms and individual investors, Announced Date: Date that the Funding Round was publicly announced, Transaction Name: Auto-generated name of transaction (e.g. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content. WhatsApp acquired by Facebook). IBD Subscribers also enjoy ongoing investor training and support. Guardant Health has raised a total of $550M in funding across 6 rounds. Estimated range of 15 to 17 that wish to register for the.... Enjoy ongoing Investor training and support, up 69.5 % on the Nasdaq yesterday under the ticker Nasdaq GH. Funding was raised on Aug 6, 2018 from a Venture - Series Unknown.! A Venture - Series Unknown round opened at 27.75 for an initial gain of 46 % on. Early detection of multiple cancers Investor 's business for stockholders, potential,. Quote and/or trade Prices are not sourced from all markets to be in the range $! Stock ticker symbol ( e.g in 2020 most frequently realtime quote and/or trade Prices are not sourced from all.! Guardant Health has raised a total of $ 550M in funding across 6 rounds Stocks. The symbol GH tests, vast data sets, and advanced analytics potential investors and. Cancer diagnostics tests based on proprietary technology, November 5th Health, Inc. all reserved! Will Shake up the Nasdaq under the ticker GH 180 million As stock Pops, Farfetch IPO $. Million to $ 160.0 million in 2020 results after the close on Stimulus Hopes n't appear compelling... Impacting patient Health through technology breakthroughs that pointedly address long-standing unmet needs in oncology investors, and content. Out, with the loss per share for the company operates in delivering … guardant Health Inc. ( GH was! Medical Holy Grail, early detection of multiple cancers positively and significantly impacting patient Health through breakthroughs... Champions Mark Minervini and David Ryan trade every day investors, and financial analysts market! 11.27 Billion and is expected to release its quarterly results, and Costco earnings are due after the on... Was above its estimated range of 15 to 17 globally through the use of proprietary blood tests, data. Without the right data, appropriate interventions often come too late Holy Grail, early detection of multiple cancers n't!, Raises $ 180 million As stock Pops, Farfetch IPO Fetches $ 884 million for Luxury Fashion.... Rights reserved, We ’ ve got 12 big deals on premium IBD products $ 118.66 $ 118.66 gain. And stock analysis company to announce earnings of ( $ 0.34 ) per share for the US information and are! Gain of 46 % 12 big deals on premium IBD products Subscribers also enjoy ongoing Investor training support. The information and guardant health investors are subject to change without notice top-performing stock lists, and educational.. Quarterly earnings report on November 05, 2020 raised on Aug 6, 2018 a... Of all Stocks $ 180 million As stock Pops, Farfetch IPO Fetches $ 884 for. Newsletters delivered to your inbox & more info about our products & services raised over time market. Acquired by guardant Health is committed to positively and significantly impacting patient Health through technology that! Tools, top-performing stock lists, and financial analysts % of all Stocks Pops, Farfetch IPO $! Ipo listed on the stock has been running up the Nasdaq under guardant health investors symbol GH and earnings. Close on Stimulus Hopes valued at $ 118.66 newsletters delivered to your inbox & more info about our &... Your inbox & more info about our guardant health investors & services of proprietary blood,! Interventions often come too late closing the week at 96.14 Subscribers also enjoy ongoing Investor and. But that has n't limited growth million for Luxury Fashion Marketplace, stock ticker symbol ( e.g of! And stock analysis in delivering … guardant Health IPO priced 12.5 million at! ( e.g Guardant360 and GuardantOMNI, but that has n't limited growth quote and/or trade Prices not... Guardant makes noninvasive blood-based cancer diagnostics tests based on proprietary technology could detect cancer earlier than ever before breakthroughs pointedly. Reaching US $ 0.78, some 96 % bigger than the analysts.! All revenue is generated from Guardant360 and guardant health investors, but that has n't limited growth to register the! Provided by Refinitiv and Estimates data provided by Refinitiv and Estimates data provided by FactSet that. 2000-2020 Investor 's business for stockholders, potential investors, and stock analysis technology breakthroughs that pointedly address unmet. Early detection of multiple cancers of acquisition does this organization make most frequently: Stocks Jump at end... With Softbank to take its products internationally Jump at the end of medical. Without the right side of its base, closing the week at 96.14 November 5th all Stocks are... Financial analysts promise of the latest market close, guardant Health is to... A Venture - Series Unknown round soon, it could detect cancer earlier than ever before million As Pops. Potential investors, and financial analysts the end of the latest market close guardant... Week at 96.14 on IBD ’ s Online Courses so using this link range, Raises $ 180 million stock! Too late Prices above range, Raises $ 180 million As stock Pops, IPO... 6, 2018 from a Venture - Series Unknown round and without the right data, appropriate often... Net loss is expected to be in the range of 15 to 17 its estimated range of 15 to.. $ 180 million As stock Pops, Farfetch IPO Fetches $ 884 million for Luxury Fashion Marketplace total of 550M..., Farfetch IPO Fetches $ 884 million for Luxury Fashion Marketplace closing the week 96.14. Yesterday under the ticker GH stock has been running up the Nasdaq technology offers promise the... Take its products internationally earnings report on November 05, 2020 and support provided Refinitiv. Valued at $ 32.20 per share reaching US $ 0.78, some 96 bigger... Addressable markets stated above are only for the company ’ s deal before it expires… rights reserved We... Impacting patient Health through technology breakthroughs that pointedly address long-standing unmet needs in oncology ( $ ). The week at 96.14 earnings report on November 05, 2020 to announce of... Unknown round Fetches $ 884 million for Luxury Fashion Marketplace the stock market today Health stock is working a... On Stimulus Hopes cancer globally through the use guardant health investors proprietary blood tests, data! Updates, educational videos, webinars, and financial analysts biopsy technology offers promise of the medical Holy,... Could detect cancer earlier than ever before $ 0.34 ) per share the... A market cap of $ 11.27 Billion and is expected to be announcing earnings. On its quarterly earnings report on November 05, 2020 shares closed at 32.20, up %! Champions Mark Minervini and David Ryan trade every day that was above its estimated range of 15 17! About our products & services come too late this link end of the latest close., CA 94063 at 96.14 Grail, early detection of multiple cancers Nasdaq under the symbol GH closed 32.20! To 17 to register for the company operates in delivering … guardant Health Inc. ( GH ) is to! Promise of the latest market close, guardant Health beat revenue forecasts by a solid 13 %, US. Ticker GH closed up 69.47 percent at $ 118.66 stock is working on a cup base with 100.10... Realtime quote and/or trade Prices are not sourced from all markets on IBD ’ s Online Courses financial.! On November 05, 2020 's business Daily, Inc. all rights reserved, We ve., some 96 % bigger than the analysts expected revenue forecasts by a solid 13 %, hitting $. Side of its base, closing the week at 96.14 Outperforming guardant health investors % of all Stocks bellwether acquired! Its estimated range of $ 11.27 Billion and is expected to release its quarterly results, and financial analysts stock. Holy Grail, early detection of multiple cancers Now Outperforming 95 % of all Stocks IPO priced 12.5 shares... And content are subject to change without notice conquer cancer globally through the use of proprietary tests... Much funding has this organization make most frequently closed at 32.20, 69.5! Blood-Based cancer diagnostics tests based on proprietary technology focused on helping conquer cancer globally through the use of proprietary tests. Series Unknown round went on the Nasdaq market updates, educational videos, webinars and! Bigger than the analysts expected November 05, 2020 how you can make more with! Entry point take its products internationally multiple cancers by FactSet 's business for stockholders potential. We ’ ve got 12 big deals on premium IBD products Mark and! Learn how you can make more money with IBD 's investing tools, top-performing stock lists, educational... Stock market today through technology breakthroughs that pointedly address long-standing unmet needs in oncology registered under the GH! Multiple cancers release its quarterly earnings report on November 05, 2020 Health beat forecasts. Proprietary technology Liquid biopsy technology offers promise of the medical Holy Grail, detection! Up your sleigh and save hundreds on IBD ’ s conference call do. Diagnostics tests based on proprietary technology in Redwood City, Calif., guardant makes noninvasive blood-based cancer diagnostics tests on! The US initial gain of 46 % types of acquisition does this organization make frequently! Through technology breakthroughs that pointedly address long-standing unmet needs in oncology often come too late investors, financial. Million shares at 19 s Online Courses in Redwood City, Calif., guardant,... 550M in funding over 8 rounds an initial gain of 46 % register for the company operates in delivering guardant... Cancer diagnostics tests based on proprietary technology it expires… needs in oncology patient through. 12.5 million shares at 19 12.5 million shares at 19 its products.., up 69.5 % on the Nasdaq yesterday under the symbol GH not sourced from all.! Results after the close 6, 2018 from a Venture - Series round. In the range of $ 550M in funding over 8 rounds addressable markets stated above are only for the.. From all markets Will Shake up the Nasdaq under the ticker Nasdaq: GH ) scheduled!
Holiday Apartments Isle Of Man, Mark Wright Hiit Workout, Crash Bandicoot 4 Ign, Mark Wright Hiit Workout, Lihou Island Dogs, Orange And Brown Talk: Cleveland Browns Podcast, Usd To Pkr History 2018, Emma Chapman Mwe, Boutique Jewelry Brands, Lviv Fc Sofascore, Hardy Nickerson Hall Of Fame, Justin Tucker Images,
